ClinicalTrials.gg
Status unknownNCT00901953Updated May 15, 2009

Vestibular System in Migrainous Vertigo Patients

An observational study in Migraine Disorders, Migraine Variant and Episodic Recurrent Vertigo, sponsored by University of Bergen. Status unknown at 1 site in Norway. Open to participants aged 16 Years to 61 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-05-15.

Sponsored by University of Bergen · Observational

The sponsor has not verified this record recently (last verified May 2009), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
65
Ages
16 Years to 61 Years
Sex
All
01

Study summary

Do migrainous vertigo patients have more pathology in their vestibular system than migraine patients without vertigo?

The aim of this study is to compare the vestibular system of migraine patients with and without vertigo in the symptom-free period by vestibular function tests, videonystagmography, vestibular evoked myogenic potentials, and subjective visual vertical.

02

Conditions studied

  • Migraine Disorders
  • Migraine Variant
  • Episodic Recurrent Vertigo

Keywords

  • migraine
  • migrainous vertigo
  • vestibular evoked myogenic potentials
  • vestibular function test
  • vestibular disorders
03

In context

Migraine Disorders

1,657 studies on the registry are indexed under Migraine Disorders; 339 are open to participants now.

This study's planned enrollment of 65 is below the median of 137 across 331 observational studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

University of Bergen is the lead sponsor of 143 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 61 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Migraine patients: primary care clinic

Migrainous vertigo patients: Neurological outpatients clinic, Sorlandet Hospital HF, Kristiansand and Spesialistsenteret, Tollbodgata 4, Kristiansand.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • migraine according to IHS criteria
  • migrainous vertigo according to the Neuhauser-criteria

Exclusion criteria

Exclusion Criteria:

  • no history of other neurological, vestibular, opthalmologic and ENT disorders
  • no medications that could possibly influence test results
  • intact hearing measured by audiometry
  • pregnancy
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
65 participants (estimated)

Groups and cohorts

  • 1

    migrainous vertigo

  • 2

    migraine without vertigo

06

What researchers measure

Primary outcomes

  1. Differences in vestibular function

    Time frame: Symptomfree interval

Secondary outcomes

  1. Differences in hypersensitivity

    Time frame: Symptomfree interval

07

Study locations

1 site
  • Dept. of neurology, Sørlandet Hospital HF
    Kristiansand, 4604, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00901953
Collaborators
Sorlandet Hospital HF
First posted
May 14, 2009
Start date
May 2007
Primary completion
May 2009
Completion
Sep 2009 (estimated)
Last update
May 15, 2009

Study contacts

Åse Mygland, PhD
principal investigator · Institute of clinical medicine, university of Bergen, Norway

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion